share_log

大华继显:大幅调高神威药业(02877.HK)目标价至11.8港元

Dahua Jixian: significantly increase the target price of Shenwei Pharmaceutical (02877.HK) to HK $11.80

金融界 ·  Jun 1, 2021 13:45

Original title: Dahua Jixian: significantly increase the target price of Shenwei Pharmaceutical (02877.HK) to HK $11.80 Source: Caihua Network

[Caihua Social News] Dahua continued to issue a report that substantially raised the target price of Shenwei Pharmaceutical (02877.HK) from HK $8.44 to HK $11.8, an increase of 39.8% or HK $6.52, with an investment rating of "buy". The report points out that Shenwei Pharmaceutical continues to recover from the novel coronavirus epidemic this year. As China opens up the traditional Chinese medicine formula granule industry to market competition, Shenwei is ready to expand the market. Shenwei Pharmaceutical reported a 37 per cent year-on-year increase in revenue in the first quarter of 2021 to 744 million yuan, and continued strong growth in all its businesses.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment